首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD2 Recombinant Antibody

Anti-Human CD2 Recombinant Antibody

产品编号

YR1030

别名

科研级 Siplizumab ( 西利珠单抗 ), Anti-CD2 Recombinant Antibody, Research Grade Siplizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Siplizumab ( 西利珠单抗 ), Anti-CD2 Recombinant Antibody, Research Grade Siplizumab
Catalog NumberYR1030
Molecular NameSiplizumab
HostRat
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundSiplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.
CAS Number288392-69-8
ApplicationELISA, IP, FCM, FuncS, Neut, IF, ICC
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD2[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价